Calder Biosciences Inc. logo — Improving & Saving Lives with the second generation of subun...

Calder Biosciences Inc.

Improving & Saving Lives with the second generation of subunit vaccines to protect against life-threatening diseases.

Founded 2018 United States Brooklyn, United States 8 employees Seed Total: $9.00M Biopharma, Biotechnology +1

General Information

Company Name Calder Biosciences Inc.
Founded Year 2018
Location United States Brooklyn, United States +1
Founders / Decision Makers
Team member
Employees 8
Industries Biopharma, Biotechnology, Health Care
Funding Stage Seed
Social

Get notified when Calder Biosciences Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Calder Biosciences Inc.

Calder Biosciences Inc. is a promising biopharma and biotechnology startup founded in 2018 that has caught the attention of venture capital firms. The company is focused on developing the next generation of subunit vaccines to combat life-threatening diseases, with a particular emphasis on respiratory syncytial virus (RSV) and universal influenza vaccines. Having secured a $625.00K Seed Round investment on 12 September 2023 from notable backers including SOSV, indiebio, and the Genesis Consortium, Calder Biosciences has positioned itself as a key player in the quest to improve and save lives. The company's pioneering nano-scale molecular engineering approach holds the potential to address significant unmet medical needs in the market while minimizing clinical risk. With a strong foothold in the United States, Calder Biosciences is set to make a substantial impact in the healthcare industry.

Taxonomy: Calder Biosciences, vaccines, influenza, RSV, nanotechnology, immunology, respiratory diseases, clinical research, viral outbreaks, molecular engineering, biopharmaceuticals, protein science, pre-clinical development, immunogens

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor Investor
24 Apr 2024
Seed Round •••••• 3
Investor Investor Investor
12 Sep 2023
Grant •••••• - 06 Jul 2023
Grant •••••• - 21 Mar 2022
Grant •••••• 1 •••• •••• 15 Feb 2020

View All 9 Funding Rounds

Calder Biosciences Inc. Alternatives & Competitors

Calder Biosciences Inc. vs

Clintract is a leading clinical research organization providing clinical trial management services

1 employees
Calder Biosciences Inc. vs

Experience that leads to innovation

136 employees
Calder Biosciences Inc. vs
INTEGRIUM LTD
INTEGRIUM LTD United States

We are entrusted with advancing the medical treatment of humankind.

1 employees

FAQ About Calder Biosciences Inc.

Improving & Saving Lives with the second generation of subunit vaccines to protect against life-threatening diseases.
Calder Biosciences Inc. was founded in 2018.
Calder Biosciences Inc. is headquartered in Brooklyn, United States.
Calder Biosciences Inc. operates in the following industries: Biopharma, Biotechnology, Health Care.
Calder Biosciences Inc. has approximately 8 employees.
Calder Biosciences Inc. has completed 9 funding rounds, raising a total of $9.00M. The latest funding stage is Seed.
Top alternatives and competitors to Calder Biosciences Inc. include Clintract Clinical Research, Inc., Intrials Clinical Research, INTEGRIUM LTD, Data Magik Ltd, R.grid. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Calder Biosciences Inc. and Clintract Clinical Research, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Calder Biosciences Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes